688443 Chongqing Genrix Biopharmaceutical
- 31.00
- -0.92-2.88%
Chongqing Genrix Biopharmaceutical News
Zhixiang Jintai: Repurchase Report on the Repurchase of Shares Using Centralized Bidding Transactions
Repurchase Report on the Repurchase of Shares through Centralized Auction Transactions
Zhixiang Jintai: Announcement on the progress of share repurchases
Announcement on the progress of share repurchases
Zhixiang Jintai: Third Quarter Report 2024
Third Quarter Report 2024
Zhixiang Jintai: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Announcement on the shareholding situation of the top ten shareholders and the top ten shareholders with unlimited sale conditions for share repurchases
Zhixiang Jintai: Announcement of Resolutions of the 16th Meeting of the First Board of Directors
Zhixiang Jintai: A Plan to Repurchase Shares Through Centralized Bidding
Announcement of Resolutions of the 16th Meeting of the First Board of Directors
A plan for repurchasing shares through centralized bidding
Zhixiang Jintai Investor Relations Activity Record Form (2024 Semi-Annual Results Briefing)
Announcement on the listing and circulation of part of the initial public offering of restricted shares
Inspection opinions of Haitong Securities Co., Ltd. on the initial public offering of Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. and the listing circulation of some restricted shares
Announcement on holding the 2024 semi-annual results briefing
An indicative announcement on the chairman\'s proposal to repurchase the company\'s shares
Haitong Securities Co., Ltd.\'s 2024 continuous supervision semi-annual follow-up report on Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd.
Special Report on the Deposit and Actual Use of Funds Raised for the Semiannual Year of 2024
Announcement of Resolutions of the 14th Meeting of the First Board of Supervisors
Analysis
Price Target
No Data
No Data